Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia. We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor. Loss of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway and c-Myc. Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APC min mice. These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.
Introduction
mSin3, N-CoR, and SMRT, which recruit HDACs to transcription factors (Glass and Rosenfeld, 2000) . HDAC inhibitors are conCarcinogenesis is a multistep process during which cells acquire sidered as candidate drugs in therapy for leukemia, but apparseveral critical features due to genetic instability and alterations ently also in various other forms of cancer, including those of in gene expression (Hanahan and Weinberg, 2000) . In promyelononhematopoietic origin (Johnstone, 2002; Krä mer et al., 2001 ; cytic leukemia, a prominent cause is the expression of fusion Marks et al., 2001; Melnick and Licht, 2002; Remiszewski, 2002) . proteins from chromosomal translocations that code for aberHowever, compared to the fusion proteins serving aberrant tranrant transcriptional repressors due to inappropriate recruitment scriptional repressor functions in leukemia, little is known about of histone deacetylases (HDACs) ; Melnick genetic causes for aberrant repression in epithelial forms of and Licht, 2002) . The recruitment of histone acetyltransferases cancer. and HDACs is considered to be a key element in the dynamic Colonic cancer is frequently associated with aberrant signalregulation of many genes regulating cellular proliferation and ing through the Wnt pathway due to loss of both functional differentiation during normal development and carcinogenesis copies of the tumor suppressor adenomatosis polyposis coli (Berger, 2002; Glass and Rosenfeld, 2000; Jenuwein and Allis, (APC) and/or mutations in the ␤-catenin gene, although addi-2001; Strahl and Allis, 2000) . Mammalian histone deacetylases tional mutations are required for cancer development (Fodde, can be divided into three subclasses (Verdin et al., 2003) . HDACs 2003; Giles et al., 2003; Kinzler and Vogelstein, 1996) . APC is 1, 2, 3, and 8, which are homologs of the yeast RPD3 protein, a key component of the ␤-catenin destruction complex that is constitute class I. HDACs related to the yeast Hda1 protein form required for basal turnover and Wnt-induced stabilization of class II, and mammalian homologs of the yeast Sir2 protein ␤-catenin. Wnt signaling prevents GSK-3␤-dependent phosconstitute the third class. HDACs are usually subunits of multiphorylation and subsequent APC-dependent degradation of ␤-catenin. Loss of functional APC leads to reduced turnover protein complexes, for example the transcriptional corepressors
S I G N I F I C A N C E
HDAC inhibitors are considered promising novel anticancer drugs, and prove useful in preclinical and first clinical trials. Nevertheless, little is known about whether aberrant transcriptional repression plays a role in the development of solid tumors, or which might be the critical components of the transcriptional repression machinery. Knowledge of mechanisms of faulty HDAC-dependent transcriptional repression acquired during the development of solid tumors would allow screening for such forms of cancer that can be expected to respond to therapy with HDAC inhibitors. Also, specific isoenzymes in the family of more than ten HDACs may be identified which appear as particular relevant targets for the development of isoenzyme-specific HDAC inhibitors. and accumulation of ␤-catenin protein. Although ␤-catenin influences a number of cellular processes, the primary function of accumulated ␤-catenin in intestinal cancer development appears to be mediated by interaction with the Tcf-4/Lef1 transcription factors (Behrens et al., 1996; Molenaar et al., 1996; Morin, 1999) . Known target genes are Cyclin D1 (Shtutman et al., 1999; Tetsu and McCormick, 1999 ), c-Myc (He et al., 1998 ), and PPAR␦ (He et al., 1999 , among several other target genes of the Wnt pathway (http://www.stanford.edu/rnusse/pathways/ targets.html). Only for some of these genes has a link to the transformed phenotype of cancer cells been established.
We now show a link between tumor suppression in colonic cancer and aberrant transcriptional repression. Loss of functional APC leads by a Myc-dependent mechanism to overexpression of an apparently rate-limiting component of the transcriptional repression machinery, HDAC2. High expression of HDAC2 is required and sufficient to maintain a transformed cellular phenotype with respect to the lack of apoptosis in cultured colonic cancer cells. Increased expression of HDAC2 in APC mutant mice and severe reduction of adenoma formation upon interference with HDAC2 indicate that HDAC2 is a critical target of APC in vivo that is accessible to pharmacological interventions.
Results
Wild-type APC represses HDAC2 expression APC-deficient HT-29 colonic cancer cells fail to grow in the presence of HDAC inhibitors (Gö ttlicher et al., 2001 ). Therefore, we tested whether APC status affects HDAC expression by using HT-29 cells in which wild-type APC is expressed from a Zn 2ϩ -inducible transgene (Morin et al., 1996) . Expression of HDAC2 was significantly reduced, both at the mRNA (to 42% at 48 hr) and protein (to 21% from 48 hr onward) levels after induction of wild-type APC ( Figures 1A and 1B) . Downregulation of PPAR␦ mRNA (to 21% at 48 hr) served as control for APC reconstitution. Expression of ␤-Gal instead of APC proved spec- Stambolic et al., 1996) . HDAC2 mRNA as controls.
(data not shown) and protein expression was elevated by 4.1-E: Occupancy of the binding site for c-Myc in the HDAC2 promoter was fold upon ␤-catenin accumulation ( Figure 1C ). Lithium also in- Figure 1D ), while ␤-catenin levels were unchanged. These data PPAR␦. A role of c-Myc is likely, since the promoter region that (82%), and more than 1 score point difference between normal and tumor tissue was found on average ( Figure 2B ). In the vast harbors a binding site for c-Myc at 621 to 616 bp upstream of the HDAC2 start codon is occupied with c-Myc in HT-29 cells majority of samples, HDAC2 and ␤-catenin were regulated in the same way, suggesting that they are, in most cases, as shown by chromatin immunoprecipitation (ChIP) assays. Expression of wild-type APC by Zn2 ϩ induction virtually abolished related events in the development of colonic cancer ( Figure 2B ). Only 5 samples did not show elevated HDAC2 levels despite promoter occupancy with c-Myc ( Figure 1E ). The functional significance of Myc was tested by siRNA transfection. siRNA immunologically detectable increased levels of ␤-catenin, which could be due to additional defects in the ␤-catenin/Tcf pathway. efficiently knocked down Myc protein expression by 49% and HDAC2 expression by 67%, whereas, as expected, ␤-catenin Elevated HDAC2 expression without apparent increases in ␤-catenin levels was observed in 11 samples. This may be due levels were not affected ( Figure 1F ). Downregulation of HDAC2 appears to be even more pronounced than that of c-Myc, which to the limited quantitative power of immunohistochemistry, or it may indicate that HDAC2 expression and accumulation may be due to the timing of the experiment.
of ␤-catenin are not always associated. Other mechanisms of HDAC2 upregulation, such as Myc amplification may exist in Elevated HDAC2 levels in human colonic cancer addition to APC/␤-catenin signaling. The separate analysis of We compared 57 samples of mostly moderately differentiated TNM-T3 or -T4 tumors versus patient-matched normal tissues 6 mucinous type, 11 well differentiated, or 2 poorly differentiated samples, respectively, did not yield any significant difference with respect to alterations in HDAC2 and ␤-catenin levels ( Figure  2A ). Elevated HDAC2 expression was observed in 47 samples compared to the analysis of all samples. Neither did the analysis of the 11 classical tumor sections with tumor and normal tissue control cultures displayed no difference in growth kinetics (Figure 3C ). The significant reduction of cell numbers does not present on the same slide differ significantly from the evaluation of all samples together. As a general conclusion from the immuappear to be due to lack of proliferation, since the distribution of cells over G1 and S/G2 phases of the cell cycle was not nohistochemical analysis, elevated HDAC2 levels are found at an even higher frequency in colonic cancer samples than elealtered ( Figure 3D ). A substantial fraction of cells with sub-G1 amounts of DNA rather suggests that knockdown of HDAC2 or vated ␤-catenin levels in the present or published studies (Hugh et al., 1999; Valizadeh et al., 1997) .
VPA treatment of HT-29 cells might induce apoptosis. Induction of apoptosis upon HDAC2 knockdown was confirmed by counting cells with fragmented and condensed nuclear DNA and HDAC2 is required for HT-29 cell survival Expression of wild-type APC in HT-29 cells in culture had been a quantitative assay for cytoplasmic histone-associated DNA fragments ( Figure 3E ). In summary, the knockdown data suggest shown to reduce cell numbers and to induce apoptosis (Morin et al., 1996 , and our unpublished data). To test whether lack of that HDAC2 is required for HT-29 cell survival, and that downmodulation to a level comparable to that in APC-proficient cells HDAC2 alone would suffice to impair HT-29 cell growth, we knocked down HDAC2 protein levels to less than 30% by transsuffices to induce apoptosis. Similar experiments addressing HDAC3 achieved reduction of protein levels by only 50%, withfection of siRNA directed against HDAC2 ( Figure 3A) . Downmodulation of HDAC2 occurred on the mRNA level, indicating a out detectable effects on cell survival (data not shown).
The critical role of HDAC2 in the prevention of apoptosis specific activity of the siRNA ( Figure 3B ). Cell cultures transfected with HDAC2 siRNA showed significantly reduced growth, was confirmed by a second independent approach, which should also clarify whether ectopic expression of HDAC2 alone with cell counts reduced by more than 50% after 3 days, while late the need for additional proapoptotic signals upon reconstitution of wild-type APC. Also, additional antiapoptotic signals in addition to high-level HDAC2 expression in APC-deficient cells do not need to be postulated from the present experiments, since overexpression of HDAC2 alone suffices to substantially protect from initiation of apoptosis upon reconstitution of wildtype APC (Figures 1 and 3) . Nevertheless, other mechanisms to control apoptosis may exist downstream of APC that are not apparent in the present experiments but may exist in other cell types or under other experimental conditions.
The APC/␤-catenin/HDAC2 pathway in mice To test whether HDAC2 is a relevant target of the APC/␤-catenin pathway in vivo, we analyzed HDAC2 in APC min and Apc   1638N mice (Fodde et al., 1994; Shoemaker et al., 1997; Su et al., 1992) . HDAC2 protein levels are elevated in intestinal polyps of APC min mice compared to normal tissue ( Figure 5A ). In wild- compared to normal tissues of wild-type mice. HDAC3 expression did not differ between wild-type and APC mutant mice ( Figure 5B and histology not shown), whereas HDAC7 levels rather appeared to be lower in tumors. In contrast to adenomas suffices to prevent apoptosis. HDAC2 was expressed from a expressing only mutant APC due to somatic inactivation of transiently transfected vector, while endogenous HDAC2 was the second allele, normal intestinal epithelium of heterozygous downregulated by Zn , 2003; . Increased bulk ciently transfected cells had to be protected from apoptosis.
histone H3 acetylation indicated efficiency of HDAC inhibition, Control transfection of the empty vector together with GFP did and reduction of HDAC2 levels but not of HDAC3 was confirmed not enrich transfected cells. These data indicate a prominent by immunohistochemistry ( Figure 5C and data not shown). VPA role of overexpressed HDAC2 in protection of APC-proficient significantly reduced number and average size of adenomas cells from apoptosis. They suggest that elevated HDAC2 exin entire intestinal tracts ( Figures 5D and 5E ). Particularly, only pression is a key mechanism in prevention of apoptosis in APC-10% of the large tumors (diameter Ͼ 1 mm) were found after VPA deficient cells.
treatment. In summary, the analysis of APC min mice supports The possibility cannot be excluded that APC affects apoptothe conclusion that loss of functional APC also leads to insis also by additional mechanisms. Those, however, appear creased HDAC2 expression in vivo, and that aberrant HDAC unlikely to be able to overcome the control mediated by HDAC2 activity is required for development of APC min dependent intestiin HT-29 cells. Reconstitution of wild-type APC or transfection nal adenomas. of siRNA in APC-deficient cells reduces HDAC2 protein levels to a similar extent. In the latter case, HDAC2 depletion suffices Discussion to induce apoptosis despite the lack of functional APC. If it is assumed that reduction of HDAC2 expression upon reconstituElevated expression of HDAC2 upon increased signaling through the APC/␤-catenin/c-Myc pathway establishes an extion of wild-type APC expression likewise provides a functionally equivalent proapoptotic stimulus, one would not have to postuample for aberrant function of the HDAC-dependent transcrip- tional repression machinery in nonhematopoietic cancer cells.
lished data). Sulindac is thought to interfere with DNA binding of PPAR␦ (He et al., 1999) and reduces HDAC2 expression by Elevated HDAC2 expression prevents apoptosis in cultured cells, and interference with HDACs reduces tumor formation in 50% in HCT116, but only marginally in HT-29 cells (P.Z. and M.G., unpublished data). Human xenograft growth in mice sub-APC min mice. APC regulates HDAC2 most likely at the transcriptional level, stantially depends on PPAR␦, whereas adenoma development in APC min mice does not (Barak et al., 2002; Park et al., 2001) . because APC does not affect the initial rate of HDAC2 mRNA degradation after inhibition of de novo synthesis by actinomycin Thus, different components of the Wnt pathway contribute to HDAC2 expression and Tcfs, c-Myc, occasionally PPAR␦, and D (data not shown). Interference by a dominant-negative mutant of Tcf suggests that either Tcf-4/Lef1 or a Tcf-4/Lef1-depenprobably Ras are prominent factors. Induction of HDAC2 upon loss of APC represents a novel dently induced protein such as c-Myc or PPAR␦ induces HDAC2 transcription (He et al., 1998 (He et al., , 1999 . Sequence analysis and mechanism for aberrant function of the HDAC-dependent transcriptional repression machinery upon genetic defects that pro-EMSA analyses of the HDAC2 promoter (Zeng et al., 1998) suggested that this could be c-Myc. Experimental evidence for mote the development of cancer. Such links are sparse in carcinomas in contrast to numerous examples in leukemia (Krä mer a functional role of c-Myc in expression of HDAC2 is provided here by showing reduction of HDAC2 expression upon knocket al., 2001; Melnick and Licht, 2002) . The polycomb group protein enhancer of zeste 2 apparently promotes prostate candown of c-Myc. c-Myc expression is also elevated by protein stabilization upon K-Ras activation (Sears et al., 1999) . Therecer development by HDAC-dependent transcriptional repression (Varambally et al., 2002) . The BRCA tumor suppressors fore, activation of this protooncogene with critical roles in colonic cancer development is likely to increase HDAC2 expresfunction as both transcriptional activators and repressors. It is, however, not clear if and how this is related to carcinogenesis sion. PPAR␦ appears to contribute to HDAC2 regulation in some cell types. Disruption of one PPAR␦ allele in embryonic stem (Monteiro, 2000; Scully, 2001) . A link between tumor development in APC-deficient mice and regulation of gene expression cells reduces HDAC2 expression by 50% (P.Z. and M.G., unpub-and chromatin structure had been described in DNA methylcarcinoma, because HDAC2 expression is elevated in most of the human colonic cancer samples. Furthermore, 4 out of 8 transferase (DNMT)-deficient mice. Genetic inactivation of one of the DNMT alleles and chemical inhibition by 5-aza-deoxycytihuman colonic cancer cell lines showed a strong reduction of cellular biomass upon VPA treatment, while the remaining ones dine severely reduced the numbers of polyps formed (Laird et al., 1995) . The concepts of DNA methyltransferase and histone showed a moderate decrease (E.M., unpublished data). Since progression of cancer requires many cellular features, it is likely acetylation might address related aspects of the same biological process in colon tumorigenesis, in which histone deacetylation that combinations of drugs targeting different pathways will be appropriate with HDAC2 inhibitors supporting induction of might provide the most dynamic and transient mode of downregulation of critical target genes. At later stages, this downreguapoptosis in cancer cells. lation may become more stably established by DNA methylation.
Experimental procedures
The recruitment of individual HDACs and HDAC-containing complexes to critical target genes by transcription factors might Cell culture and transfections provide a level of specificity that is not apparent from alterations Cell culture and transgene induction by 100 M Zn 2ϩ have been described in bulk DNA methylation rates. The present data and preliminary (He et al., 1999; Krä mer et al., 2003) . Plasmid and siRNA were transfected gene expression profiles obtained after knockdown of HDAC2
with Lipofectamine 2000 and Oligofectamine (Invitrogen, Carlsbad, California) according to the manufacturer's instructions. Briefly, the HDAC2 expres-(data not shown) indicate that critical processes during carcinosion vector pCMV-mRPD3-2.1 (Yang et al., 1996) APC min mice upon HDAC inhibition is also due to apoptosis.
RT-PCR
Apoptosis rates were below detection limits in wild-type and First-strand cDNA was generated using the RNeasy and Oligotex mRNA mutant mice, possibly due to rapid shedding of apoptotic cells mini kits (Qiagen, Hilden, Germany) and Superscript II Reverse Transcriptase from the epithelium (data not shown). TGTGCCCAT-3Ј and 5Ј-CTCTTGCTCGAAGTCCAGGG-3Ј.
VPA serves as a model drug. It has been used in therapy of epilepsy for decades and induction of differentiation in cancer
Chromatin immunoprecipitation cells had been described (Blaheta and Cinatl, 2002) . Only re-HT29-APC and HT29-␤GAL cells were treated with 100 M ZnCl 2 for 18 hr cently has it become apparent that VPA preferentially inhibits as indicated. Cells were fixed in 1% formaldehyde and harvested for preparthe catalytic activity of class I HDACs (Gö ttlicher et al., 2001;  ing nuclei in lysis buffer (50 mM Hepes [pH 8], 1 mM EDTA, 0.5 mM EGTA, 150 mM NaCl, 10% glycerol, 0.5% NP40, 0.2% Triton X-100, protease and, in addition, induces proteasomal degrainhibitors cocktail [Roche, Mannheim, Germany] , 2001) . VPA treatment is likely to be successful not only protein A sepharose CL-4B and 5 g sheared salmon sperm DNA for 2 hr, immunoprecipitation was performed with 5 g of a specific anti-c-Myc antiduring adenoma formation, but also after development of the body (sc-764, Santa Cruz Biotechnology, California) overnight at 4ЊC. Protein APC cells, pcDNA/Myc-⌬N-hTcf4, pCMV-mRPD3-2.1, and mPPAR␦ cDNA, A Sepharose (25 l) and 10 g/ml salmon sperm DNA were added for respectively). The study was supported by the Forschungszentrum Karlsruhe another 1 hr. Precipitates were washed sequentially in RIPA buffer, RIPA (fellowship to P.Z.) and the AICR, St. Andrews, UK (grant to M.G.). E.M. and buffer with 10 g/ml salmon sperm DNA, RIPA buffer with 10 g/ml salmon J.M. are employees of G2M Cancer Drugs AG, which has a financial interest sperm DNA and 500 mM NaCl, and RIPA. Precipitate-associated DNA was in inhibitors of histone deacetylases. eluted with 50 mM Tris-HCl (pH 8), 1 mM EDTA, 100 mM NaCl, 0.5% SDS, 100 g/ml proteinase K for 3 hr at 55ЊC and then overnight at 65ЊC, and purified with a QIAquick Spin Kit (Qiagen, Hilden, Germany). DNA was used for PCR detection with the following primers: c-Myc biding site flanking
